AshoorIFDharnidharkaVR. Non-immunologic allograft loss in pediatric kidney transplant recipients. Pediatr Nephrol. 2019;34(2):211-222. doi: 10.1007/s00467-018-3908-4.
2.
El-GhonemyMSEl SharawySFahmiMWEl-AshwahSDenewerMEl-BaiomyMA. Thrombophilic risk of factor V Leiden, prothrombin G20210A, MTHFR, and calreticulin mutations in essential thrombocythemia Egyptian patients. Adv Hematol. 2020;2020:7695129. doi: 10.1155/2020/7695129.
3.
van den BergTAJNieuwenhuijs-MoekeGJLismanTMoersCBakkerSJLPolRA. Pathophysiological changes in the hemostatic system and antithrombotic management in kidney transplant recipients. Transplantation. Epub ahead of print. 2022 Dec 19. doi: 10.1097/TP.0000000000004452
4.
ShenEUemuraTKadryZSathishkumarS. Successful living donor kidney transplantation in a patient with prothrombin gene mutation: case report and literature review. J Anaesthesiol Clin Pharmacol. 2014;30(1):106-108. doi: 10.4103/0970-9185.125718.
5.
HuangMWuWZhangQ, et al.Single kidney transplantation from pediatric deceased donors in China: the outcomes and risk factors of graft survival. Transl Pediatr. 2022;11(11):1872-1885. doi: 10.21037/tp-22-547.
